ARMISTICE CAPITAL, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Enlivex Therapeutics Ltd. Ordinary Shares, par value NIS 0.40 per share (AUTL)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Enlivex Therapeutics Ltd. Ordinary Shares, par value NIS 0.40 per share
Symbol: AUTL
Shares outstanding: 23,615,010 shares
Disclosed Ownership: 1,178,389 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 20:46:30 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	5%	1,178,389	0	1,178,389	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	5%	1,178,389	0	1,178,389	/s/ Steven Boyd	Steven Boyd